Skip to main content
. Author manuscript; available in PMC: 2020 Sep 17.
Published in final edited form as: Cancer Lett. 2015 Nov 12;370(2):324–331. doi: 10.1016/j.canlet.2015.11.005

Fig. 4.

Fig. 4.

Comparison of the distribution of driver mutations identified in NSCLC tDNA and plasma ctDNA samples. (A) Mutation rates of EGFR, KRAS, PIK3CA, TP53, BRAF, and ERBB2 in the 42 sample pairs; (B) Rates of mutation types (SNPs vs. indels; n = 42 samples). (C) Pie chart showing the distribution of driver mutations identified in matched primary NSCLC tDNA and plasma ctDNA.